1. Home
  2. OCUL vs DXPE Comparison

OCUL vs DXPE Comparison

Compare OCUL & DXPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • DXPE
  • Stock Information
  • Founded
  • OCUL 2006
  • DXPE 1908
  • Country
  • OCUL United States
  • DXPE United States
  • Employees
  • OCUL N/A
  • DXPE N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • DXPE Industrial Machinery/Components
  • Sector
  • OCUL Health Care
  • DXPE Industrials
  • Exchange
  • OCUL Nasdaq
  • DXPE Nasdaq
  • Market Cap
  • OCUL 2.3B
  • DXPE 1.9B
  • IPO Year
  • OCUL 2014
  • DXPE 1996
  • Fundamental
  • Price
  • OCUL $11.48
  • DXPE $122.46
  • Analyst Decision
  • OCUL Strong Buy
  • DXPE Buy
  • Analyst Count
  • OCUL 9
  • DXPE 1
  • Target Price
  • OCUL $22.63
  • DXPE $95.00
  • AVG Volume (30 Days)
  • OCUL 3.1M
  • DXPE 152.4K
  • Earning Date
  • OCUL 11-04-2025
  • DXPE 11-06-2025
  • Dividend Yield
  • OCUL N/A
  • DXPE N/A
  • EPS Growth
  • OCUL N/A
  • DXPE 47.94
  • EPS
  • OCUL N/A
  • DXPE 5.24
  • Revenue
  • OCUL $56,664,000.00
  • DXPE $1,919,100,000.00
  • Revenue This Year
  • OCUL N/A
  • DXPE $10.99
  • Revenue Next Year
  • OCUL $17.75
  • DXPE $6.65
  • P/E Ratio
  • OCUL N/A
  • DXPE $23.39
  • Revenue Growth
  • OCUL N/A
  • DXPE 13.93
  • 52 Week Low
  • OCUL $5.79
  • DXPE $48.89
  • 52 Week High
  • OCUL $13.85
  • DXPE $130.97
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 45.90
  • DXPE 54.00
  • Support Level
  • OCUL $11.38
  • DXPE $109.13
  • Resistance Level
  • OCUL $11.78
  • DXPE $118.61
  • Average True Range (ATR)
  • OCUL 0.50
  • DXPE 5.37
  • MACD
  • OCUL -0.01
  • DXPE 0.42
  • Stochastic Oscillator
  • OCUL 30.89
  • DXPE 74.78

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About DXPE DXP Enterprises Inc.

DXP Enterprises Inc is a distributor of products and services to industrial customers in the United States, Canada, Mexico, and Dubai. The company's reportable segments include Service Centers, Innovative Pumping Solutions, and Supply Chain Services. It generates maximum revenue from the Service Centers segment. The company offers pumping solutions, supply chain services and maintenance, repair, operating, and production services for rotating equipment, bearings, power transmissions, industrial supplies, and safety products. It serves the General Industrial, Oil & Gas, Food & Beverage, Water & Wastewater, Chemical, Transportation, Aerospace & Others.

Share on Social Networks: